MDT Medtronic Plc

  1. Stocks
  2. Healthcare
  3. NYSE: MDT

Price (delayed)

$90.58

Market cap

$115.95B

P/E Ratio

24.15

Dividend/share

$2.85

EPS

$3.75

Enterprise value

$141.96B

?
Relative Growth: Rel. Growth: 66
Relative Strength: Rel. Strength: 42
Relative Valuation: Rel. Valuation: 51
Relative Profitability: Rel. Profitability: 69

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity ...

Highlights
The price to earnings (P/E) is 11% lower than the 5-year quarterly average of 27.2 and 4.2% lower than the last 4 quarters average of 25.2
MDT's gross profit is up by 8% year-on-year and by 2.7% since the previous quarter
Medtronic's quick ratio has increased by 13% YoY but it has decreased by 12% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.medtronic.com
Peers: BSX SYK EW JNJ

Key stats

What are the main financial stats of MDT

MDT stock price

How has the Medtronic stock price performed over time
Intraday
-0.2%
1 week
5.42%
1 month
8.39%
1 year
-2.51%
YTD
-5.7%
QTD
15.79%

Financial performance

How have Medtronic's revenue and profit performed over time
Revenue
$36.36B
Gross profit
$23.64B
Operating income
$6.47B
Net income
$4.8B
Gross margin
65%
Net margin
13.2%
The operating income has increased by 9% YoY and by 7% QoQ
MDT's gross profit is up by 8% year-on-year and by 2.7% since the previous quarter
Medtronic's revenue has increased by 8% YoY and by 2.5% from the previous quarter
The operating margin has increased by 4.7% since the previous quarter

Price vs fundamentals

How does MDT's price correlate with its fundamentals

Growth

What is Medtronic's growth rate over time

Valuation

What is Medtronic stock price valuation
MDT P/E details
P/E
24.15
P/B
2.35
P/S
3.19
EV/EBIT
20.83
EV/EBITDA
14.53
EV/Sales
3.9
The price to earnings (P/E) is 11% lower than the 5-year quarterly average of 27.2 and 4.2% lower than the last 4 quarters average of 25.2
The EPS rose by 4.2% since the previous quarter and by 3.3% year-on-year
The company's equity rose by 3% YoY
The stock's price to book (P/B) is 2.1% less than its 5-year quarterly average of 2.4 and 2.1% less than its last 4 quarters average of 2.4
MDT's P/S is 11% lower than its 5-year quarterly average of 3.6 and 6% lower than its last 4 quarters average of 3.4
Medtronic's revenue has increased by 8% YoY and by 2.5% from the previous quarter

Efficiency

How efficient is Medtronic business performance
The company's return on invested capital rose by 8% QoQ
The return on sales rose by 6% since the previous quarter
MDT's return on assets is up by 4% since the previous quarter
Medtronic's return on equity has increased by 3.2% QoQ and by 2.1% YoY

Dividends

What is MDT's dividend history
Dividend details
DPS
$2.85
Dividend yield
3.15%
Payout ratio
76%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Medtronic financials performed over time
The total assets is 117% greater than the total liabilities
The company's current ratio fell by 16% QoQ but it rose by 15% YoY
Medtronic's quick ratio has increased by 13% YoY but it has decreased by 12% from the previous quarter
MDT's debt is 43% smaller than its equity
Medtronic's debt to equity has decreased by 3.4% YoY
The company's equity rose by 3% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.